An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumorsRobert M. Jotte, Robert Ilaria, Fadi Braiteh et al.|Investigational New Drugs|2014Cited by 10